Breaking News Instant updates and real-time market news.

LOXO

Loxo Oncology

$83.23

2.05 (2.53%)

13:48
11/14/17
11/14
13:48
11/14/17
13:48

Loxo Oncology upgraded to Strong Buy from Outperform at IFS Securities

IFS Securities analyst David Bouchey upgraded Loxo Oncology to Strong Buy and raised his price target for the shares to $155 from $115. The company this morning announced a global partnership with Bayer (BAYRY) to develop and commercialize larotrectinib and LOXO-195. JMP Securities also upgraded Loxo intraday.

  • 14

    Nov

  • 29

    Nov

LOXO Loxo Oncology
$83.23

2.05 (2.53%)

09/29/17
BTIG
09/29/17
NO CHANGE
BTIG
Loxo Oncology price target raised to $102 from $75 at BTIG
BTIG analyst Dane Leone raised his price target on Loxo after the company reported data on its LOXO-292 drug. The analyst says that the results were positive, leading him to include revenue from the drug in his model for the company. He says that the data "provides compelling evidence of clinical activity," and he keeps a Buy rating on the shares.
10/20/17
SBSH
10/20/17
NO CHANGE
Target $112
SBSH
Buy
Loxo Oncology price target raised to $112 from $86 at Citi
Citi analyst Yigal Nochomovitz raised his price target for Loxo Oncology to $112 citing a more bullish stance on LOXO-292. The RET Inhibitor will emerge with "similar highly promising efficacy/duration" data as the Phase 1 data mature, with substantial similarity to larotrectinib's overall data path, Nochomovitz tells investors in a research note. The analyst now models probability adjusted U.S. peak sales of $540M. He reiterates a Buy rating on Loxo.
11/14/17
COWN
11/14/17
NO CHANGE
COWN
Outperform
Loxo agreement in best interest of shareholders, says Cowen
Cowen analyst Eric Schmidt says that while Loxo Oncology's (LOXO) collaboration with Bayer (BAYRY) "will turn a few heads" since it includes 50% of U.S. rights, it represents a "solid monetization" of the company's TRK inhibitor franchise. Further, the analyst notes optimism before the agreement that Loxo might be an acquisition candidate ahead of larotrectinib's 2018 launch could be contributing to today's selloff. The deal is in the best interests of shareholders and $1B in nearer-term payments is substantial, Schmidt contends. He believes the agreement can be seen as one that monetizes a good portion of the TRK franchise value for upfront cash. The analyst keeps an Outperform rating on Loxo Oncology. The stock in early trading is down 5% to $79.11.
11/14/17
JMPS
11/14/17
UPGRADE
Target $95
JMPS
Outperform
Loxo Oncology upgraded to Outperform from Market Perform at JMP Securities
JMP Securities analyst Michael King upgraded Loxo Oncology (LOXO) to Outperform from Market Perform and set a $95 price target on the stock after the company announced a global partnership with Bayer (BAYRY) to develop and commercialize larotrectinib and LOXO-195.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

14:17
11/21/17
11/21
14:17
11/21/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
11/21/17
11/21
14:16
11/21/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$34.91

-0.21 (-0.60%)

, PFE

Pfizer

$35.61

0.2648 (0.75%)

14:05
11/21/17
11/21
14:05
11/21/17
14:05
Hot Stocks
FDA approves ViiV Healthcare's two drug HIV treatment Juluca »

The FDA today said it…

GSK

GlaxoSmithKline

$34.91

-0.21 (-0.60%)

PFE

Pfizer

$35.61

0.2648 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 07

    Dec

  • 14

    Dec

OCLR

Oclaro

$6.49

-0.09 (-1.37%)

14:05
11/21/17
11/21
14:05
11/21/17
14:05
Options
Oclaro call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

  • 12

    Dec

NUE

Nucor

$56.02

0.46 (0.83%)

14:04
11/21/17
11/21
14:04
11/21/17
14:04
Hot Stocks
Nucor announces plans to build rebar micro mill »

Nucor announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTK

Cytokinetics

$11.10

-0.7 (-5.93%)

14:01
11/21/17
11/21
14:01
11/21/17
14:01
Recommendations
Cytokinetics analyst commentary  »

Cytokinetics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CYTK

Cytokinetics

$11.10

-0.7 (-5.93%)

13:59
11/21/17
11/21
13:59
11/21/17
13:59
Recommendations
Cytokinetics analyst commentary  »

Cytokinetics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

SSNLF

Samsung

, WHR

Whirlpool

$166.91

1.71 (1.04%)

13:58
11/21/17
11/21
13:58
11/21/17
13:58
Periodicals
ITC calls for tariff-rate quota on imported Samsung, LG washers, Reuters says »

The U.S. International…

SSNLF

Samsung

WHR

Whirlpool

$166.91

1.71 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RF

Regions Financial

$15.70

-0.16 (-1.01%)

13:55
11/21/17
11/21
13:55
11/21/17
13:55
Options
Regions Financial put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLMT

Calumet Specialty Products

$8.30

0.1 (1.22%)

13:53
11/21/17
11/21
13:53
11/21/17
13:53
Hot Stocks
Calumet Specialty Products announces divestiture of Anchor Drilling Fluids »

Calumet Specialty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITUS

ITUS

$3.16

0.25 (8.59%)

13:53
11/21/17
11/21
13:53
11/21/17
13:53
Conference/Events
ITUS to hold a pharmaceutical update conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENBL

Enable Midstream

$15.03

-0.0315 (-0.21%)

13:49
11/21/17
11/21
13:49
11/21/17
13:49
Downgrade
Enable Midstream rating change  »

Enable Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STLY

Stanley Furniture

$0.93

0.0349 (3.92%)

13:47
11/21/17
11/21
13:47
11/21/17
13:47
Hot Stocks
Stanley Furniture to sell substantially all its assets »

As previously reported,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:40
11/21/17
11/21
13:40
11/21/17
13:40
General news
NY Fed's overnight reverse repo totaled $42.9 B (19 counterparties) »

NY Fed's overnight…

EYE

National Vision

$30.19

0.21 (0.70%)

13:33
11/21/17
11/21
13:33
11/21/17
13:33
Initiation
National Vision initiated  »

National Vision initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

CYTK

Cytokinetics

$11.10

-0.7 (-5.93%)

13:32
11/21/17
11/21
13:32
11/21/17
13:32
Downgrade
Cytokinetics rating change  »

Cytokinetics downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

LOW

Lowe's

$81.59

0.13 (0.16%)

13:27
11/21/17
11/21
13:27
11/21/17
13:27
Recommendations
Lowe's analyst commentary  »

Lowe's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

WHR

Whirlpool

$165.67

0.47 (0.28%)

13:25
11/21/17
11/21
13:25
11/21/17
13:25
Periodicals
ITC suggests tariffs on washing machine imports above 1.2M units, Bloomberg says »

Two of four ITC officials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWI

Armstrong World

$53.70

-0.15 (-0.28%)

13:25
11/21/17
11/21
13:25
11/21/17
13:25
Conference/Events
Armstrong World to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BMO

Bank of Montreal

$77.39

0.06 (0.08%)

13:21
11/21/17
11/21
13:21
11/21/17
13:21
Hot Stocks
BMO Financial Group enters partnership with CDL-Montreal »

BMO Financial Group and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:20
11/21/17
11/21
13:20
11/21/17
13:20
General news
Fed Governor Powell's hearings for the position as Fed Chair »

Fed Governor…

PG

Procter & Gamble

$88.93

0.66 (0.75%)

13:20
11/21/17
11/21
13:20
11/21/17
13:20
Options
Buyer lays out 500K for three month upside in Procter and Gamble »

Buyer lays out 500K for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

13:17
11/21/17
11/21
13:17
11/21/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
11/21/17
11/21
13:16
11/21/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$49.71

-0.21 (-0.42%)

13:05
11/21/17
11/21
13:05
11/21/17
13:05
Options
CSX call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.